ZHONGXING LIAO to Neoplasms
This is a "connection" page, showing publications ZHONGXING LIAO has written about Neoplasms.
Connection Strength
0.209
-
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role? Drugs. 2007; 67(6):821-45.
Score: 0.044
-
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial. Lancet Oncol. 2022 10; 23(10):1321-1331.
Score: 0.033
-
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment. Curr Oncol Rep. 2022 05; 24(5):543-553.
Score: 0.032
-
Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol. 2021 Mar; 60(3):312-315.
Score: 0.029
-
Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19. Radiother Oncol. 2020 07; 148:252-257.
Score: 0.028
-
Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncol. 2019 Aug; 58(8):1135-1137.
Score: 0.026
-
Reducing the toxicity of cancer therapy: recognizing needs, taking action. Nat Rev Clin Oncol. 2012 07 03; 9(8):471-8.
Score: 0.016